The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
Clinical trial NCT07156773 · RECRUITING
Trial details
- NCT number
- NCT07156773
- Sponsor
- Guangzhou Novaken Pharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2026-03-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.